Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- SEHA showcases breakthrough advances in stem cell research and treatment of motor and sensory spinal injurieson February 1, 2020 at 9:17 pm
Abu Dhabi Health Services Company (SEHA), the UAE’s largest healthcare network, welcomed medical experts to a Grand Rounds Event titled ‘Use of Stem Cells in the Treatment of Spinal Cord Injury’ with ...
- Stem Cells, But Which Flavor?on February 1, 2020 at 1:39 pm
Whenever I discuss stem cell therapies with non-biologist friends, I’m struck by how confused they often are about what stem cells actually are and what they do. There is particular confusion in ...
- Isolation of tissue-resident vascular endothelial stem cells from mouse liveron January 31, 2020 at 8:39 am
However, isolation of fresh ECs from adult mice to investigate this further is challenging. Here, we describe an easy and reproducible protocol for isolation of different types of ECs and CD157 + ...
- Unlawful stem cell products continue to harm people as FDA deadline loomson January 31, 2020 at 7:00 am
Congressional oversight could boost efforts to ensure safe, effective regenerative therapies.
- Multi-platform NMR Study of Pluripotent Stem Cells Unveils Complementary Metabolic Signatures towards Differentiationon January 31, 2020 at 3:42 am
Stem cells, poised to revolutionize current medicine, stand as major workhorses for monitoring changes in cell fate. Characterizing metabolic phenotypes is key to monitor in differentiating cells ...
- Scientists boost gene-editing tools to new heights in human stem cellson January 31, 2020 at 12:40 am
These limitations have frustrated scientists such as Arizona State University's David Brafman, a cell bioengineer. Brafman initial hopes are to use gene editing to get at the heart of uncovering the ...
- Cancer Stem Cells Market Expected to Generate Revenue of $ 1,722.7 Million, Growing at a CAGR of 10.3% by 2026on January 30, 2020 at 4:00 am
/PRNewswire/ -- According to Research Dive, Global Cancer Stem Cells Market will reach upto $1,722.7 million by the end of year 2026. Increasing number ...
- Stem cell clinics’ much-hyped treatments lack scientific supporton January 30, 2020 at 3:31 am
Her doctors chalked it up to wear and tear. “ ‘You’re getting older,’ ” she remembers them telling her. This was in early 2018. Then she got an e-mail with a link to a video about stem cells and the ...
- Column: U.S. judge rejects FDA bid to shut down stem cell clinics, dealing blow to regulatorson January 29, 2020 at 3:09 pm
A Los Angeles federal judge has rejected a government motion that could have shut down a network of clinics offering customers allegedly unauthorized stem cell treatments. The ruling by Judge Jesus G.
- Molecular motors direct the fate of stem cellson January 29, 2020 at 11:06 am
Scientists at the University of Groningen and the University Medical Center Groningen used molecular motors to manipulate the protein matrix on which bone marrow-derived mesenchymal stem cells are ...
via Bing News